American Well (AMWL) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
3 Feb, 2026Opening remarks and agenda
Meeting called to order by the Chair, with board members and auditors present via virtual platform.
Shareholders instructed on meeting conduct and Q&A procedures, with investor relations contact provided.
Corporate governance
Notice of proxy materials distributed to shareholders of record; meeting declared properly called.
Quorum established with approximately 77.8% of voting power represented.
Independent inspector of elections appointed to oversee voting process.
Board and executive committee updates
Three nominees presented for election as Class I directors to serve until the 2027 annual meeting.
All nominees present via phone; no other nominations made; board recommends voting for all nominees.
Partial view of Summaries dataset, powered by Quartr API
Latest events from American Well
- Director election, auditor ratification, and executive pay were key AGM agenda items.AMWL
AGM 202616 Jun 2026 - Dr. Roy Schoenberg will not seek re-election, and no substitute director will be nominated.AMWL
Proxy filing9 Jun 2026 - Strong Q1 results and major government contracts position the company for profitable growth by 2027.AMWL
21st Annual Needham Technology, Media, & Consumer Conference14 May 2026 - Q1 2026 revenue fell 18%, but net loss narrowed and positive cash flow is targeted for Q4.AMWL
Q1 20266 May 2026 - Key votes include director elections, auditor ratification, and executive pay approval.AMWL
Proxy filing23 Apr 2026 - 2025 saw major cost reductions, platform innovation, and strong governance ahead of key shareholder votes.AMWL
Proxy filing23 Apr 2026 - 2026 guidance targets $195–$205M revenue, EBITDA breakeven, and strong government contract momentum.AMWL
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - Margins improved and losses narrowed, with positive cash flow targeted for Q4 2026.AMWL
Q4 202512 Feb 2026 - Q2 revenue rose to $62.8M, losses narrowed, and 2024 EBITDA guidance improved.AMWL
Q2 20242 Feb 2026